index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

56 Publications avec texte intégral

Open Access

46 %

Mots clés

Mass cytometry CyTOF Chronicity CD31 CXCL13-CXCR5 Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Neuromuscular junction Chronic inflammation Interferon Lamin A/C nuclei PBMC Follicular hyperplasia Interféron de type I Cellules th17 DICER CCL21 Human myoblasts B cells Auto-immunité Myasthénie grave Fragile X syndromes Gender Immune response FMR1 Gd T cells Experimental models Maladie auto-immune Macrophages Germinal centers COVID-19 AChR antibodies COX2 Age Quality of life Chemokines Animal models M3243AG Interferon de type I MYB Long-term follow-up Genetics Acides nucléiques endogènes Myasthenia Gravis MG Antimir-150 Disease susceptibility Centres germinatifs ectopiques Germinal center Acetylcholine receptors Immunity Interferon type I Thymus Exercise Autoimmune diseases Transcriptome Th17 cells Ectopic germinal centers Cardiomyopathy Immune regulation Interleukine-23 Inflammatory cytokines Innate immunity Experimental autoimmune myasthenia gravis EAMG Interferonopathy Chemokine Autoimmune disease Myasthenia gravis Adaptive immunity Etiology Genetic associations Complete Freund's adjuvant Interleukin 23 Thymoma Interferon type-I Endogenous nucleic acids Glucocorticoids Myoblasts Il-23 Early-onset myasthenia gravis Thymic epithelial cells Cytokines Interferon-β Ferrites Inflammation BAFF Max Acetylcholine receptor Immunotherapy Heart failure Clinical cell transplantation Acetylcholine receptor antibodies Conduction disease Interferon IFN Experimental autoimmune myasthenia gravis Anticorps monoclonal Experimental mouse models Autoimmunity CTCF LMNA Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration MG patients Immunology and Microbiology Section